Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Total
Preferred Stock
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Beginning Balance (in shares) at Dec. 31, 2021   0 39,692,373      
Beginning Balance at Dec. 31, 2021 $ 696,304,000 $ 0 $ 4,000 $ 121,844,000 $ 573,546,000 $ 910,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net and comprehensive (loss) income 71,079,000       74,951,000 (3,872,000)
Dividends (52,136,000)       (52,136,000)  
Stock-based compensation 8,131,000     8,131,000    
Shares issued pursuant to employee stock purchase plan (in shares)     11,089      
Shares issued pursuant to employee stock purchase plan 414,000     414,000    
Issuance of common stock for settlement of deferred stock units (in shares)     166,449      
Issuance of common stock for vesting of restricted stock units (in shares)     212,234      
Issuance of common stock for unvested restricted stock awards (in shares)     11,494      
Shares withheld related to net share settlement of stock-based awards (in shares)     (158,020)      
Shares withheld related to net share settlement of stock-based awards (8,039,000)     (8,039,000)    
Issuance of common stock for stock settled deferred consideration (in shares)     28,673      
Issuance of stock for the settlement of deferred consideration 1,417,000     1,417,000    
Ending Balance (in shares) at Jun. 30, 2022   0 39,964,292      
Ending Balance at Jun. 30, 2022 717,170,000 $ 0 $ 4,000 123,767,000 596,361,000 (2,962,000)
Beginning Balance (in shares) at Mar. 31, 2022   0 39,795,399      
Beginning Balance at Mar. 31, 2022 675,389,000 $ 0 $ 4,000 122,782,000 554,193,000 (1,590,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net and comprehensive (loss) income 40,796,000       42,168,000 (1,372,000)
Stock-based compensation 4,275,000     4,275,000    
Shares issued pursuant to employee stock purchase plan (in shares)     11,089      
Shares issued pursuant to employee stock purchase plan 414,000     414,000    
Issuance of common stock for settlement of deferred stock units (in shares)     166,449      
Issuance of common stock for vesting of restricted stock units (in shares)     44,971      
Issuance of common stock for unvested restricted stock awards (in shares)     11,494      
Shares withheld related to net share settlement of stock-based awards (in shares)     (93,783)      
Shares withheld related to net share settlement of stock-based awards (5,121,000)     (5,121,000)    
Issuance of common stock for stock settled deferred consideration (in shares)     28,673      
Issuance of stock for the settlement of deferred consideration 1,417,000     1,417,000    
Ending Balance (in shares) at Jun. 30, 2022   0 39,964,292      
Ending Balance at Jun. 30, 2022 717,170,000 $ 0 $ 4,000 123,767,000 596,361,000 (2,962,000)
Beginning Balance (in shares) at Dec. 31, 2022   0 39,255,838      
Beginning Balance at Dec. 31, 2022 713,509,000 $ 0 $ 4,000 131,541,000 585,581,000 (3,617,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net and comprehensive (loss) income (13,545,000)       (14,562,000) 1,017,000
Dividends (10,284,000)       (10,284,000)  
Stock-based compensation 10,362,000     10,362,000    
Shares issued pursuant to employee stock purchase plan (in shares)     15,297      
Shares issued pursuant to employee stock purchase plan 392,000     392,000    
Issuance of common stock for vesting of restricted stock units (in shares)     337,796      
Issuance of common stock for unvested restricted stock awards (in shares)     17,339      
Shares withheld related to net share settlement of stock-based awards (in shares)     (125,319)      
Shares withheld related to net share settlement of stock-based awards (3,986,000)     (3,986,000)    
Issuance of common stock for stock settled deferred consideration (in shares)     58,205      
Issuance of stock for the settlement of deferred consideration 1,833,000     1,833,000    
Repurchases of common stock (in shares)     (1,098,561)      
Repurchases of common stock (34,362,000)       (34,362,000)  
Ending Balance (in shares) at Jun. 30, 2023   0 38,460,595      
Ending Balance at Jun. 30, 2023 663,919,000 $ 0 $ 4,000 140,142,000 526,373,000 (2,600,000)
Beginning Balance (in shares) at Mar. 31, 2023   0 38,876,354      
Beginning Balance at Mar. 31, 2023 682,158,000 $ 0 $ 4,000 132,905,000 551,696,000 (2,447,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net and comprehensive (loss) income (8,882,000)       (8,729,000) (153,000)
Stock-based compensation 5,351,000     5,351,000    
Shares issued pursuant to employee stock purchase plan (in shares)     15,297      
Shares issued pursuant to employee stock purchase plan 392,000     392,000    
Issuance of common stock for vesting of restricted stock units (in shares)     43,923      
Issuance of common stock for unvested restricted stock awards (in shares)     17,339      
Shares withheld related to net share settlement of stock-based awards (in shares)     (11,885)      
Shares withheld related to net share settlement of stock-based awards (339,000)     (339,000)    
Issuance of common stock for stock settled deferred consideration (in shares)     58,205      
Issuance of stock for the settlement of deferred consideration 1,833,000     1,833,000    
Repurchases of common stock (in shares)     (538,638)      
Repurchases of common stock (16,594,000)       (16,594,000)  
Ending Balance (in shares) at Jun. 30, 2023   0 38,460,595      
Ending Balance at Jun. 30, 2023 $ 663,919,000 $ 0 $ 4,000 $ 140,142,000 $ 526,373,000 $ (2,600,000)